Search research articles
Contact Us
Filters
Showing results (131-140 of 186) with videos related to
Page
of 19
Sort By:
Gynecologic Oncology
|
February 9, 2016
Treatment related outcomes in high-risk endometrial carcinoma: Canadian high risk endometrial cancer consortium (CHREC)
Marcus Q Bernardini, Lilian T Gien, Susie Lau, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 28, 2023
p53-Abnormal "Fields of Dysplasia" in Human Papillomavirus-Independent Vulvar Squamous Cell Carcinoma Impacts Margins and Recurrence Risk
Emily F Thompson, Richard W C Wong, Giorgia Trevisan, et al.
Histopathology
|
January 15, 2025
Prognostic values of molecular subtypes and SWI/SNF protein expression in de-differentiated/undifferentiated endometrial carcinoma
Chae Young Shin, Bengul Gokbayrak, Valerie L Tao, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 9, 2020
Improving response to progestin treatment of low-grade endometrial cancer
Eva Baxter, Donal J Brennan, Jessica N McAlpine, et al.
The American Journal of Surgical Pathology
|
October 1, 2013
Histotype-genotype correlation in 36 high-grade endometrial carcinomas
Lien N Hoang, Melissa K McConechy, Martin Köbel, et al.
The Journal of Pathology
|
April 14, 2025
Activated immune infiltrates expand opportunities for targeted therapy in p53-abnormal endometrial carcinoma
Spencer D Martin, Shelby Thornton, Christine Chow, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 14, 2015
Polymerase Epsilon Exonuclease Domain Mutations in Ovarian Endometrioid Carcinoma
Lien N Hoang, Melissa K McConechy, Martin Köbel, et al.
Gynecologic Oncology
|
September 10, 2015
Canadian high risk endometrial cancer (CHREC) consortium: analyzing the clinical behavior of high risk endometrial cancers
Alon D Altman, Sarah E Ferguson, Eshetu G Atenafu, et al.
Oncotarget
|
November 16, 2017
Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials
Helen J MacKay, Douglas A Levine, Victoria L Bae-Jump, et al.
Human Pathology
|
October 30, 2020
Whole-proteome analysis of mesonephric-derived cancers describes new potential biomarkers
Evan Gibbard, Dawn R Cochrane, Jennifer Pors, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 186) with videos related to
Sort By:
Page
of 19
Gynecologic Oncology
|
February 9, 2016
Treatment related outcomes in high-risk endometrial carcinoma: Canadian high risk endometrial cancer consortium (CHREC)
Marcus Q Bernardini, Lilian T Gien, Susie Lau, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 28, 2023
p53-Abnormal "Fields of Dysplasia" in Human Papillomavirus-Independent Vulvar Squamous Cell Carcinoma Impacts Margins and Recurrence Risk
Emily F Thompson, Richard W C Wong, Giorgia Trevisan, et al.
Histopathology
|
January 15, 2025
Prognostic values of molecular subtypes and SWI/SNF protein expression in de-differentiated/undifferentiated endometrial carcinoma
Chae Young Shin, Bengul Gokbayrak, Valerie L Tao, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 9, 2020
Improving response to progestin treatment of low-grade endometrial cancer
Eva Baxter, Donal J Brennan, Jessica N McAlpine, et al.
The American Journal of Surgical Pathology
|
October 1, 2013
Histotype-genotype correlation in 36 high-grade endometrial carcinomas
Lien N Hoang, Melissa K McConechy, Martin Köbel, et al.
The Journal of Pathology
|
April 14, 2025
Activated immune infiltrates expand opportunities for targeted therapy in p53-abnormal endometrial carcinoma
Spencer D Martin, Shelby Thornton, Christine Chow, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 14, 2015
Polymerase Epsilon Exonuclease Domain Mutations in Ovarian Endometrioid Carcinoma
Lien N Hoang, Melissa K McConechy, Martin Köbel, et al.
Gynecologic Oncology
|
September 10, 2015
Canadian high risk endometrial cancer (CHREC) consortium: analyzing the clinical behavior of high risk endometrial cancers
Alon D Altman, Sarah E Ferguson, Eshetu G Atenafu, et al.
Oncotarget
|
November 16, 2017
Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials
Helen J MacKay, Douglas A Levine, Victoria L Bae-Jump, et al.
Human Pathology
|
October 30, 2020
Whole-proteome analysis of mesonephric-derived cancers describes new potential biomarkers
Evan Gibbard, Dawn R Cochrane, Jennifer Pors, et al.
Page
of 19